Propanc Biopharma Inc (PPCB)

Currency in USD
9.49000
+1.99000(+26.53%)
Closed·
PPCB Scorecard
Full Analysis
Significant return over the last week
PPCB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.490009.49000
52 wk Range
1.25000145.46000
Key Statistics
Prev. Close
9.49
Open
7.49
Day's Range
7.49-9.49
52 wk Range
1.25-145.46
Volume
1.66K
Average Volume (3m)
3.01K
1-Year Change
-77.4%
Book Value / Share
1.56
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PPCB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Propanc Biopharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Propanc Biopharma Inc Company Profile

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.

Compare PPCB to Peers and Sector

Metrics to compare
PPCB
Peers
Sector
Relationship
P/E Ratio
−1.6x−3.4x−0.5x
PEG Ratio
-−0.070.00
Price/Book
4.8x1.2x2.6x
Price / LTM Sales
-4.2x3.3x
Upside (Analyst Target)
-124.3%42.4%
Fair Value Upside
Unlock36.7%7.2%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-12.50 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PPCB Income Statement

People Also Watch

0.99
KLTO
+3.13%
3.490
MPU
-11.65%
0.950
GAME
-0.11%
1.740
IPA
+0.87%
0.423
LNZA
+2.92%

FAQ

What Stock Exchange Does Propanc Biopharma Trade On?

Propanc Biopharma is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Propanc Biopharma?

The stock symbol for Propanc Biopharma is "PPCB."

What Is the Propanc Biopharma Market Cap?

As of today, Propanc Biopharma market cap is 110.20M.

What Is Propanc Biopharma's Earnings Per Share (TTM)?

The Propanc Biopharma EPS (TTM) is -51.78.

From a Technical Analysis Perspective, Is PPCB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Propanc Biopharma Stock Split?

Propanc Biopharma has split 5 times.

How Many Employees Does Propanc Biopharma Have?

Propanc Biopharma has 2 employees.

What is the current trading status of Propanc Biopharma (PPCB)?

As of 31 Jul 2025, Propanc Biopharma (PPCB) is trading at a price of 9.49, with a previous close of 9.49. The stock has fluctuated within a day range of 7.49 to 9.49, while its 52-week range spans from 1.25 to 145.46.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.